(Q37386081)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19195625%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

review article

1 reference

title

The role of the lipogenic pathway in the development of hepatic steatosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19195625%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19195625%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

J Girard

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19195625%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

1 December 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19195625%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

published in

Diabetes and Metabolism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19195625%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19195625%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

6 Pt 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19195625%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

643-648

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19195625%20AND%20SRC:MED&resulttype=core&format=json

Nonalcoholic fatty liver disease as a complication of insulin resistance

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

The effect of PPARgamma ligands on the adipose tissue in insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Regulation of plasma triglycerides in insulin resistance and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Increased hepatic insulin sensitivity together with decreased hepatic triglyceride stores in hormone-sensitive lipase-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Hormone-sensitive lipase knockout mice have increased hepatic insulin sensitivity and are protected from short-term diet-induced insulin resistance in skeletal muscle and heart

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Effects of nutrients and hormones on transcriptional and post-transcriptional regulation of acetyl-CoA carboxylase in rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Effects of nutrients and insulin on transcriptional and post-transcriptional regulation of glucose-6-phosphate dehydrogenase synthesis in rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Fatty acid elongases in mammals: their regulation and roles in metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Enzymes of triacylglycerol synthesis and their regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Stearoyl-coenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X receptor activation

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Role of stearoyl-coenzyme A desaturase in regulating lipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid synthesis in liver

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Liver X receptors as integrators of metabolic and inflammatory signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Role of LXRs in control of lipogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Glucose activation of ChREBP in hepatocytes occurs via a two-step mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Glucose-dependent transcriptional regulation by an evolutionarily conserved glucose-sensing module

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Insulin sensitivity: modulation by nutrients and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Triglyceride accumulation protects against fatty acid-induced lipotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Dissociation of Hepatic Steatosis and Insulin Resistance in Mice Overexpressing DGAT in the Liver

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

Can the hyperactivity of lipogenesis cause hepatic steatosis? A role for ChREBP

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974599-3

7 January 2021

10.1016/S1262-3636(08)74599-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19195625%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference